Bio-Techne Corp
XBER:TE1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Bio-Techne Corp
XBER:TE1
|
US |
|
Wakefit Innovations Ltd
NSE:WAKEFIT
|
IN |
|
M
|
Medios AG
DUS:ILM1
|
DE |
|
UP Fintech Holding Ltd
NASDAQ:TIGR
|
CN |
|
T
|
Trane Technologies PLC
F:2IS
|
IE |
|
BRP Group Inc
NASDAQ:BWIN
|
US |
|
B
|
Bread Financial Holdings Inc
XMUN:LID
|
US |
|
L
|
Leviathan Gold Ltd
OTC:LVXFF
|
CA |
|
P
|
Persimmon PLC
OTC:PSMMY
|
UK |
|
G
|
Global Health Clinics Ltd
F:L00
|
CA |
|
Terawulf Inc
NASDAQ:WULF
|
US |
Reverse DCF
To justify the current price, Netflix Inc. must grow revenue by 36% annually over the next 5 years, which is outside the range of what's considered realistic.
| Revenue Growth Rate | DCF Value | |
|---|---|---|
|
Realistic Range
|
Realistic Low: 10%
|
$601.26
Overvalued by 45%
|
|
Historical: 21%
|
$758.26
Overvalued by 36%
|
|
|
Current DCF: 23%
|
$789.44
Overvalued by 32%
|
|
|
Wall Street: 24%
|
$831.32
Overvalued by 28%
|
|
|
Realistic High: 30%
|
$900.12
Overvalued by 12%
|
|
|
Implied by Price: 36%
|
$977.59
Matches Stock Price
|